NME1, NME/NM23 nucleoside diphosphate kinase 1, 4830
N. diseases: 317; N. variants: 8
Source: BEFREE ×
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.851 | 0.120 | 17 | 51154651 | intron variant | G/T | snv | 0.39 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.851 | 0.120 | 17 | 51154651 | intron variant | G/T | snv | 0.39 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.851 | 0.120 | 17 | 51154651 | intron variant | G/T | snv | 0.39 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.851 | 0.120 | 17 | 51154651 | intron variant | G/T | snv | 0.39 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.851 | 0.120 | 17 | 51154651 | intron variant | G/T | snv | 0.39 |
|
Pathological Conditions, Signs and Symptoms; Neoplasms | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.851 | 0.120 | 17 | 51154651 | intron variant | G/T | snv | 0.39 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.851 | 0.120 | 17 | 51154651 | intron variant | G/T | snv | 0.39 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.790 | 0.120 | 17 | 51161744 | missense variant | A/G | snv | 6.0E-05 | 7.0E-05 |
|
Neoplasms | 0.100 | 1.000 | 11 | 1995 | 2018 | ||||||
|
0.790 | 0.120 | 17 | 51161744 | missense variant | A/G | snv | 6.0E-05 | 7.0E-05 |
|
Neoplasms | 0.080 | 1.000 | 8 | 1995 | 2018 | ||||||
|
0.790 | 0.120 | 17 | 51161744 | missense variant | A/G | snv | 6.0E-05 | 7.0E-05 |
|
Neoplasms; Nervous System Diseases | 0.080 | 1.000 | 8 | 1995 | 2018 | ||||||
|
0.790 | 0.120 | 17 | 51161744 | missense variant | A/G | snv | 6.0E-05 | 7.0E-05 |
|
0.020 | 1.000 | 2 | 2003 | 2007 | |||||||
|
0.790 | 0.120 | 17 | 51161744 | missense variant | A/G | snv | 6.0E-05 | 7.0E-05 |
|
Pathological Conditions, Signs and Symptoms; Neoplasms | 0.020 | 1.000 | 2 | 2001 | 2004 | ||||||
|
0.790 | 0.120 | 17 | 51161744 | missense variant | A/G | snv | 6.0E-05 | 7.0E-05 |
|
Neoplasms | 0.010 | 1.000 | 1 | 1996 | 1996 | ||||||
|
0.790 | 0.120 | 17 | 51161744 | missense variant | A/G | snv | 6.0E-05 | 7.0E-05 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
|
0.790 | 0.120 | 17 | 51161744 | missense variant | A/G | snv | 6.0E-05 | 7.0E-05 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
|
0.790 | 0.120 | 17 | 51161744 | missense variant | A/G | snv | 6.0E-05 | 7.0E-05 |
|
Pathological Conditions, Signs and Symptoms | 0.010 | 1.000 | 1 | 1995 | 1995 | ||||||
|
0.790 | 0.120 | 17 | 51161744 | missense variant | A/G | snv | 6.0E-05 | 7.0E-05 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
|
0.925 | 0.200 | 17 | 51155707 | missense variant | G/A | snv | 6.4E-05 | 7.0E-06 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases; Stomatognathic Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
|
0.925 | 0.200 | 17 | 51155707 | missense variant | G/A | snv | 6.4E-05 | 7.0E-06 |
|
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Musculoskeletal Diseases; Stomatognathic Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
|
0.752 | 0.240 | 17 | 51153539 | 5 prime UTR variant | C/T | snv | 0.22 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2010 | 2018 | |||||||
|
0.752 | 0.240 | 17 | 51153539 | 5 prime UTR variant | C/T | snv | 0.22 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2010 | 2018 | |||||||
|
0.752 | 0.240 | 17 | 51153539 | 5 prime UTR variant | C/T | snv | 0.22 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.752 | 0.240 | 17 | 51153539 | 5 prime UTR variant | C/T | snv | 0.22 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.752 | 0.240 | 17 | 51153539 | 5 prime UTR variant | C/T | snv | 0.22 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.752 | 0.240 | 17 | 51153539 | 5 prime UTR variant | C/T | snv | 0.22 |
|
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2020 | 2020 |